[3-(2-CHLORO-6-METHYLAMINO-PURIN-9-YL)-2-(DIETHOXY-PHOSPHORYLMETHYL)-PROPYL]-PHOSPHONIC-ACID-DIETHYLESTER
Compound with spectra: 1 NMR
![[3-(2-CHLORO-6-METHYLAMINO-PURIN-9-YL)-2-(DIETHOXY-PHOSPHORYLMETHYL)-PROPYL]-PHOSPHONIC-ACID-DIETHYLESTER](/api/compound/38YcCELwaqz.png?ph=true&h=300&w=458 "[3-(2-CHLORO-6-METHYLAMINO-PURIN-9-YL)-2-(DIETHOXY-PHOSPHORYLMETHYL)-PROPYL]-PHOSPHONIC-ACID-DIETHYLESTER")
| SpectraBase Compound ID | 38YcCELwaqz |
|---|---|
| InChI | InChI=1S/C18H32ClN5O6P2/c1-6-27-31(25,28-7-2)11-14(12-32(26,29-8-3)30-9-4)10-24-13-21-15-16(20-5)22-18(19)23-17(15)24/h13-14H,6-12H2,1-5H3,(H,20,22,23) |
| InChIKey | PDRHVAGGZOGEKM-UHFFFAOYSA-N |
| Mol Weight | 511.9 g/mol |
| Molecular Formula | C18H32ClN5O6P2 |
| Exact Mass | 511.151635 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
CARBONIC-ACID-3-(2-CHLORO-6-METHYLAMINO-PURIN-9-YL)-2-PHOSPHONOOXY-METHYL-PROPYLESTER-ETHYLESTER-AMMONIUM-SALT
2,2-DIMETHYL-PROPIONIC-ACID-3-(2-CHLORO-6-METHYLAMINO-PURIN-9-YL)-2-PHOSPHONOOXY-METHYL-PROPYLESTER
BENZOIC-ACID-3-(2-CHLORO-6-METHYLAMINO-PURIN-9-YL)-2-PHOSPHONOOXY-METHYL-PROPYLESTER-AMMONIUM-SALT
2-CHLORO-9-BETA-CYANOETHYL-6-CYCLOHEXYLAMINO-PURINE
2-CHLORO-9-BETA-CYANOETHYL-6-(PARA-TOLYLAMINO)-PURINE
2-CHLORO-9-BETA-CYANOETHYL-6-(PARA-METHOXYPHENYLAMINO)-PURINE
2-CHLORO-9-BETA-CYANOETHYL-6-PHENYLAMINO-PURINE
2-CHLORO-6-CYCLOHEXYLAMINO-9-[(2-HYDROXYLETHOXY)-METHYL]-PURINE
9-[(2-ACETOXYETHOXY)-METHYL]-2-CHLORO-6-CYCLOHEXYLAMINOPURINE
9-[(2-ACETOXYETHOXY)-METHYL]-2-CHLORO-6-PHENYLAMINOPURINE
| Title | Journal or Book | Year |
|---|---|---|
| Acyclic Analogues of Adenosine Bisphosphates as P2Y Receptor Antagonists: Phosphate Substitution Leads to Multiple Pathways of Inhibition of Platelet Aggregation | Journal of Medicinal Chemistry | 2002 |